← Back to Search

Behavioral Therapy for Eating Disorders

N/A
Waitlist Available
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Require immediate treatment for medical complications as a result of eating disorder symptoms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes from each assessment time point throughout treatment (3 assessments over 16 weeks) and 6 month and 1 year post-treatment follow-up assessment
Awards & highlights
No Placebo-Only Group

Summary

This trial is designed to study the independent and combined effects of four components of mindfulness-based behavioral therapy on eating pathology. The four components are Mindful Awareness, Distress Tolerance, Emotion Modulation, and Values-Based Decision Making. The trial will compare the efficacy of each component when used alone and in combination with standard behavioral treatment for bulimia nervosa and binge eating disorder. The primary aim of the study is to evaluate the independent efficacy of each treatment component on eating pathology. Secondary aims are to test the hypotheses that the efficacy of each component is moderated by related baseline deficits in self-regulation, and to quantify the component interaction

Who is the study for?
This trial is for US residents who can participate remotely and consent to treatment. Participants must have had 12 or more episodes of losing control over eating in the past 3 months and a BMI above 16. It's not for those with severe mental health issues, non-English speakers, anyone already receiving eating disorder treatment, or needing immediate medical care.
What is being tested?
The study tests four behavioral therapy components—Mindful Awareness, Distress Tolerance, Emotion Modulation, Values-Based Decision Making—combined with standard treatment for Bulimia Nervosa (BN) and Binge Eating Disorder (BED). The goal is to see which parts help most with eating disorders by following participants up to one year.
What are the potential side effects?
Behavioral therapies like MABT typically don't cause physical side effects but may bring emotional discomfort as individuals confront difficult emotions and behaviors related to their eating disorders.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need urgent care for health issues caused by my eating disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from each assessment time point throughout treatment (3 assessments over 16 weeks) and 6-month and 1 year post-treatment follow-up assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes from each assessment time point throughout treatment (3 assessments over 16 weeks) and 6-month and 1 year post-treatment follow-up assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Binge eating frequency assessed by the Eating Disorder Examination
Eating Disorder Examination
Remission Status
Secondary study objectives
BMI
Compensatory behavior frequency assessed by the Eating Disorder Examination (EDE)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

16Treatment groups
Experimental Treatment
Active Control
Group I: Base BT + ValuesExperimental Treatment1 Intervention
16 weekly sessions of behavioral therapy with values components of MABTs.
Group II: Base BT + Mindful Awareness and ValuesExperimental Treatment2 Interventions
16 weekly sessions of behavioral therapy with values and mindful awareness components of MABTs.
Group III: Base BT + Mindful AwarenessExperimental Treatment1 Intervention
16 weekly sessions of behavioral therapy with mindful awareness components of MABTs.
Group IV: Base BT + Emotion RegulationExperimental Treatment1 Intervention
16 weekly sessions of behavioral therapy with emotion regulation components of MABTs.
Group V: Base BT + Emotion Modulation and ValuesExperimental Treatment2 Interventions
16 weekly sessions of behavioral therapy with emotion regulation and values components of MABTs.
Group VI: Base BT + Emotion Modulation and Mindful AwarenessExperimental Treatment2 Interventions
16 weekly sessions of behavioral therapy with emotion regulation and mindful awareness components of MABTs.
Group VII: Base BT + ER, MA, and VExperimental Treatment3 Interventions
16 weekly sessions of behavioral therapy with emotion regulation, mindful awareness, and values components of MABTs.
Group VIII: Base BT + ER, MA, V, DTExperimental Treatment4 Interventions
16 weekly sessions of behavioral therapy with emotion regulation, mindful awareness, distress tolerance, and values components of MABTs.
Group IX: Base BT + EM, DT, MAExperimental Treatment3 Interventions
16 weekly sessions of behavioral therapy with emotion regulation, mindful awareness, and distress tolerance components of MABTs.
Group X: Base BT + Distress Tolerance and ValuesExperimental Treatment2 Interventions
16 weekly sessions of behavioral therapy with distress tolerance and values components of MABTs.
Group XI: Base BT + Distress Tolerance and Mindful AwarenessExperimental Treatment2 Interventions
16 weekly sessions of behavioral therapy with distress tolerance and mindful awareness components of MABTs.
Group XII: Base BT + Distress Tolerance and Emotion ModulationExperimental Treatment2 Interventions
16 weekly sessions of behavioral therapy with emotion regulation and distress tolerance components of MABTs.
Group XIII: Base BT + Distress ToleranceExperimental Treatment1 Intervention
16 weekly sessions of behavioral therapy with distress tolerance components of MABTs.
Group XIV: Base BT + DT, MA, and VExperimental Treatment3 Interventions
16 weekly sessions of behavioral therapy with distress tolerance, mindful awareness, and values components of MABTs.
Group XV: Base BT + DT, ER, and VExperimental Treatment3 Interventions
16 weekly sessions of behavioral therapy with emotion regulation, distress tolerance, and values components of MABTs.
Group XVI: Base BTActive Control1 Intervention
16 weekly sessions of behavioral therapy.

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
155 Previous Clinical Trials
47,966 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,709 Total Patients Enrolled

Media Library

Behavioral Therapy for Eating Disorders Clinical Trial Eligibility Overview. Trial Name: NCT04625959 — N/A
Binge Eating Disorder Research Study Groups: Base BT, Base BT + Distress Tolerance, Base BT + Emotion Regulation, Base BT + Mindful Awareness, Base BT + Values, Base BT + Distress Tolerance and Emotion Modulation, Base BT + Distress Tolerance and Mindful Awareness, Base BT + Distress Tolerance and Values, Base BT + Emotion Modulation and Mindful Awareness, Base BT + Mindful Awareness and Values, Base BT + Emotion Modulation and Values, Base BT + EM, DT, MA, Base BT + DT, ER, and V, Base BT + DT, MA, and V, Base BT + ER, MA, and V, Base BT + ER, MA, V, DT
Binge Eating Disorder Clinical Trial 2023: Behavioral Therapy for Eating Disorders Highlights & Side Effects. Trial Name: NCT04625959 — N/A
Behavioral Therapy for Eating Disorders 2023 Treatment Timeline for Medical Study. Trial Name: NCT04625959 — N/A
~47 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top